SOVS/LVPEI Collaboration

Wednesday, 9 August, 2017 - 15:45

Type: 

Professor Mark Willcox and Dr Debarun Dutta recently visited the LV Prasad Eye Institute in Hyderabad, India to conduct an clinical trial close out and audit of data visit. The clinical trial had been partly sponsored by a Development Grant from the NH&MRC (Willcox, Kumar and Stapleton, APP1076206).

The trial was designed to examine whether an antibacterial contact lens (melimine-coated lenses) could reduce the incidence of bacterially-driven adverse events during extended wear of contact lenses. The trial was run at the LV Prasad Eye Institute by Dr Pravin Krishna (2nd from right back row), Dr Savitri Sharma (4th from left back row) and Dr Nagaraju Konda (3rd from left front row) and is the basis for the PhD studies of Mr Parthasarathi Kalaiselvan (1st right front row) who is enrolled at UNSW.  Professor Willcox said “we always enjoy our visits to the Institute, Hyderabad and India. We work with brilliant people over there who have made a mammoth effort to complete the 176-person trial."

Dr Debarun Dutta said that he thoroughly enjoyed the exchange of research excellence that took place during the visit. He was confident that this will foster more international collaborative research between Australian and Indian Research Institutes.

MACL Clinical Study Group

From front left Mr. Venkateshwara Rao, Mr. Kranthi Gautham, Dr. Nagaraju Konda, Dr. Debarun Dutta, Mr. Srikant D and Mr. Parthasarathi Kalaiselvan; from back left Ms. Pampi, Ms. Faiza, Mr. Preetam Kumar, Dr. Savitri Sharma, Prof. Mark Willcox, Dr. Raja Narayanan, Dr. Pravin Kriishna, and Dr. Mukesh Taneja.